PPARG and breast cancer: The observations indicating an impaired differentiation ability of BC ADSCs, together with literature reports describing PPARγ deregulation in breast cancer patients and its possible role as a therapeutic target [20–23], lead us to further investigate the role that this receptor could play in BC ADSC differentiation.